Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02472977
Title Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung small cell carcinoma

pancreatic adenocarcinoma

Therapies

Nivolumab

Ulocuplumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.